DK45385A - Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse - Google Patents

Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse Download PDF

Info

Publication number
DK45385A
DK45385A DK45385A DK45385A DK45385A DK 45385 A DK45385 A DK 45385A DK 45385 A DK45385 A DK 45385A DK 45385 A DK45385 A DK 45385A DK 45385 A DK45385 A DK 45385A
Authority
DK
Denmark
Prior art keywords
hexahydroarylquinolizin
pharmaceutical preparation
preparation containing
seed connection
seed
Prior art date
Application number
DK45385A
Other languages
Danish (da)
English (en)
Other versions
DK45385D0 (da
Inventor
Joel R Huff
Joseph P Vacca
John J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK45385D0 publication Critical patent/DK45385D0/da
Publication of DK45385A publication Critical patent/DK45385A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK45385A 1984-02-02 1985-02-01 Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse DK45385A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57623384A 1984-02-02 1984-02-02

Publications (2)

Publication Number Publication Date
DK45385D0 DK45385D0 (da) 1985-02-01
DK45385A true DK45385A (da) 1985-09-18

Family

ID=24303506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK45385A DK45385A (da) 1984-02-02 1985-02-01 Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse

Country Status (15)

Country Link
EP (1) EP0154142B1 (fr)
JP (1) JPS60188385A (fr)
KR (1) KR900003651B1 (fr)
AT (1) ATE44529T1 (fr)
AU (1) AU576550B2 (fr)
CA (1) CA1240677A (fr)
DE (1) DE3571438D1 (fr)
DK (1) DK45385A (fr)
ES (1) ES8609323A1 (fr)
GR (1) GR850211B (fr)
IE (1) IE850253L (fr)
IL (1) IL74147A (fr)
NZ (1) NZ210982A (fr)
PT (1) PT79871B (fr)
ZA (1) ZA85789B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690928A (en) * 1984-02-02 1987-09-01 Merck & Co., Inc. Substituted hexahydro arylquinolizines as α2 blockers
GB8420602D0 (en) * 1984-08-14 1984-09-19 Wyeth John & Brother Ltd Thienoquinolizines
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
US4835276A (en) * 1986-07-03 1989-05-30 Merck & Co., Inc. Preparation of n-formamidoyl[(s)-1-t-butoxy-3-methyl-2-amino)]1,2,3,4 tetrahydrobenzo [b]furo [2,3-c]pyridine and derivatives
US4814452A (en) * 1986-07-03 1989-03-21 Merck & Co., Inc. Enantioselective synthesis of 1,3,4,6,7,12b(S)-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin-2-one
NZ221485A (en) * 1986-08-28 1991-04-26 Merck & Co Inc Hexahydroarylquinolizine derivatives and pharmaceutical compositions
US4831035A (en) * 1986-08-28 1989-05-16 Merck & Co., Inc. Substituted hexahydroarylquinolizines
US4956365A (en) * 1987-04-13 1990-09-11 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds
CA1321751C (fr) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mecanisme mediatisant la stase ruminale dans l'acidose lactique ruminale
EP2507244B1 (fr) 2009-12-04 2014-11-05 Nerviano Medical Sciences S.r.l. Dérivés de tricyclopyrazole
GB201509006D0 (en) 2015-05-26 2015-07-08 Redx Pharma Plc Antibacterial compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470065C3 (de) * 1961-06-19 1980-07-17 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Herstellung von Chinolizinderivaten
GB1435573A (en) * 1973-05-25 1976-05-12 Wyeth John & Brother Ltd Indoloquinolizines
US4181657A (en) * 1978-07-14 1980-01-01 Miles Laboratories, Inc. 2-Aminooctahydroindolo[2,3-a]quinolizines useful in treating cardiovascular disorders
GB2106909B (en) * 1981-10-07 1984-09-19 Wyeth John & Brother Ltd Benzoquinolizines

Also Published As

Publication number Publication date
KR850005843A (ko) 1985-09-26
CA1240677A (fr) 1988-08-16
AU3822085A (en) 1985-08-08
EP0154142B1 (fr) 1989-07-12
AU576550B2 (en) 1988-09-01
ATE44529T1 (de) 1989-07-15
DK45385D0 (da) 1985-02-01
ES8609323A1 (es) 1986-07-16
ZA85789B (en) 1986-09-24
IL74147A0 (en) 1985-04-30
IL74147A (en) 1988-08-31
GR850211B (fr) 1985-05-24
EP0154142A1 (fr) 1985-09-11
JPS60188385A (ja) 1985-09-25
KR900003651B1 (ko) 1990-05-28
DE3571438D1 (en) 1989-08-17
PT79871A (en) 1985-02-01
IE850253L (en) 1985-08-02
NZ210982A (en) 1988-04-29
PT79871B (en) 1986-12-15
ES539799A0 (es) 1986-07-16

Similar Documents

Publication Publication Date Title
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
DK45385A (da) Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse
DE3685170D1 (de) Histaminderivate enthaltende pharmazeutische zusammensetzung.
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
SE8703881D0 (sv) New pharmaceutical preparation
IT8467131A0 (it) Preparazione farmaceutica a base di n"-ciano-n-4-piridil-n'-1,2,2-trime tilpropilguanidina,particolarmente per il trattamento dell'ipertensione
IL65802A (en) 1-(3-fluoro-2-pyridinyl)piperazine and salts thereof,their preparation and pharmaceutical compositions containing them
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
DK160991C (da) 5,14-dihydrobenzoe5,6aaisoindolooe2,1-baaisoquinolin-8,13-dionderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
NO873383L (no) Nye farmasoeytisk aktive (benzofurano-2-yl)imidazoler og salter derav, samt fremgangsmaate for deres fremstilling.
ES8707729A1 (es) Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.
NO870834D0 (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
NO865004L (no) Nye 16,17-acetalsubstituerte pregnan-21-oinsyrederivater og fremgangsmaate for deres fremstilling.
DE68924645D1 (de) Verabreichungsmaschine.
DK447387D0 (da) Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
IT8467927A0 (it) Preparati farmaceutici a base di dobutamina somministrabili per via orale
IT8721055A0 (it) Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
SE8704272L (sv) Pharmaceutisk komposition
IT8622783A0 (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ATE78405T1 (de) Pharmazeutische zusammensetzung, enthaltend piperidinalkanolderivate.
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
IT8822438A0 (it) Procedimento per la preparazione di ceftriaxone e i suoi sali farmaceuticamente accettabili.
NO890328L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater.
IT8586219A0 (it) Annuario tutto quartieri-tutto pae se-tutto citta'-tutto provincia-tutto regione-tutto italia,isole comprese
IT8619931A0 (it) Procedimento per la preparazione della 1-(n-metilamidino)-3-(2,6-dimetilfe nil) urea e dei suoi sali farmaceuticamente accettabili.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment